Clinical trial
A Single-Blind Prospective Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
NCT00221468 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Blind Prospective Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
- Lead sponsor
- University of Cincinnati
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- April 30, 2006
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.